Chile vs Japan: Cases started on MDR-TB treatment
Chile
61
in 2024
Japan
56
in 2023
Chile rank
83rd
Japan rank
85th
Cases started on MDR-TB treatment over time
- Chile
- Japan
How they compare
Chile currently reports 61 against 56 in Japan, a difference of 5.
That makes Chile's figure about 1.1 times Japan's.
The two have swapped places 4 times across 8 shared years of data; in 2009 it was Chile ahead.
Chile ranks 83rd and Japan ranks 85th of 191 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Japan in 1.
Head to head by decade
| Decade | Chile | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11 | 0 | 11 | Chile |
| 2010s | 20 | 62.2 | 42.2 | Japan |
| 2020s | 55.5 | 52.5 | 3 | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Chile or Japan?
- Chile, at 61 against 56 in Japan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Chile and Japan?
- 5, with Chile ahead.
- How many years of comparable data are there for Chile and Japan?
- 8 years are reported by both, from 2009 to 2023.
- How do Chile and Japan rank globally for cases started on mdr-tb treatment?
- Chile ranks 83rd and Japan ranks 85th of 191 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.